Holen Sie sich die Stockscreener-App
16.62
6.27%
0.98
Handel nachbörslich:
16.62
Schlusskurs vom Vortag:
$15.64
Offen:
$15.47
24-Stunden-Volumen:
72,347
Relative Volume:
0.67
Marktkapitalisierung:
$141.59M
Einnahmen:
$153.73M
Nettoeinkommen (Verlust:
$-106.79M
KGV:
-9.3371
EPS:
-1.78
Netto-Cashflow:
$-115.93M
1W Leistung:
+11.39%
1M Leistung:
+44.65%
6M Leistung:
+87.33%
1J Leistung:
-16.48%
1-Tages-Spanne:
$15.01
$16.77
1-Wochen-Bereich:
$14.08
$17.33
52-Wochen-Spanne:
$5.231
$21.25
Sutro Biopharma Inc Stock (STRO) Company Profile
Firmenname
Sutro Biopharma Inc
Sektor
Branche
Telefon
650-392-8412
Adresse
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie STRO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
16.62 | 133.24M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-06-16 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2025-03-14 | Herabstufung | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | Herabstufung | Wedbush | Outperform → Neutral |
| 2024-05-08 | Eingeleitet | BofA Securities | Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-06 | Eingeleitet | Oppenheimer | Outperform |
| 2023-03-21 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-09-02 | Eingeleitet | Jefferies | Buy |
| 2020-07-16 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-13 | Eingeleitet | SunTrust | Buy |
| 2019-10-07 | Eingeleitet | BTIG Research | Buy |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2019-04-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-10-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2018-10-22 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-10-22 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten
Macro Review: Should I invest in Sutro Biopharma Inc before earningsTrade Volume Summary & Weekly High Potential Alerts - baoquankhu1.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Options Flow: Is Sutro Biopharma Inc affected by consumer sentimentJuly 2025 Decliners & Risk Managed Investment Signals - baoquankhu1.vn
Winners Losers: Does MFS Government Markets Income Trust have a sustainable dividendEntry Point & Short-Term Trading Alerts - baoquankhu1.vn
Trade Recap: Is Adlai Nortye Ltd Depositary Receipt part of any ETF2025 Geopolitical Influence & Reliable Price Breakout Alerts - baoquankhu1.vn
Panic Selling: Is Sutro Biopharma Inc affected by consumer sentimentJuly 2025 Chart Watch & Growth Focused Stock Pick Reports - baoquankhu1.vn
Sutro Biopharma (STRO) Soars 5.9%: Is Further Upside Left in the Stock? - Yahoo Finance
Sutro Biopharma (NASDAQ:STRO) Upgraded to “Market Outperform” at Citizens Jmp - Defense World
Sutro Biopharma (NASDAQ:STRO) Raised to "Market Outperform" at Citizens Jmp - MarketBeat
Citizens Upgrades Sutro Biopharma (STRO) - Nasdaq
STRO Receives Upgraded Analyst Rating from Citizens | STRO Stock News - GuruFocus
Citizens JMP Upgrades Sutro Biopharma(STRO.US) to Buy Rating, Announces Target Price $23 - 富途牛牛
Citizens upgrades Sutro Biopharma stock rating to Market Outperform By Investing.com - Investing.com Canada
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 27.8% in December - MarketBeat
BofA Securities Maintains Sutro Biopharma(STRO.US) With Sell Rating, Maintains Target Price $8 - 富途资讯
Aug Decliners: Is Sutro Biopharma Inc stock a value trapQuarterly Portfolio Summary & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Sutro Biopharma: Streamlined strategy and advanced ADC pipeline drive clinical progress and differentiation - TradingView — Track All Markets
Sutro Biopharma: Accelerated ADC pipeline and strategic focus drive clinical progress and financial stability - TradingView — Track All Markets
Stock Recap: Is Sutro Biopharma Inc a potential multi baggerBull Run & Weekly Stock Breakout Alerts - baoquankhu1.vn
Volume Summary: Can Sutro Biopharma Inc reach resistance levels soonJuly 2025 Price Swings & Weekly Market Pulse Alerts - baoquankhu1.vn
Merger Talk: Why is Sutro Biopharma Inc stock going downQuarterly Profit Report & Proven Capital Preservation Tips - baoquankhu1.vn
Short Squeeze: Will Sutro Biopharma Inc stock benefit from sector rotationPortfolio Risk Summary & Detailed Earnings Play Alerts - Bộ Nội Vụ
Why millennials buy Sutro Biopharma Inc. (S09) stockMarket Trend Report & Fast Exit and Entry Strategy Plans - Улправда
Is Sutro Biopharma Inc. stock supported by strong cash flowsJuly 2025 Analyst Calls & Capital Efficiency Focused Ideas - Улправда
Is Sutro Biopharma Inc. stock a buy for dividend growth2025 Bull vs Bear & Precise Buy Zone Identification - Улправда
Is Sutro Biopharma Inc. stock undervalued vs historical averagesProfit Target & Risk Controlled Daily Plans - Улправда
Will Sutro Biopharma Inc. stock benefit from sector rotationInflation Watch & Consistent Return Strategy Ideas - ulpravda.ru
How risky is Sutro Biopharma Inc. stock nowJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - ulpravda.ru
What momentum indicators show for Sutro Biopharma Inc. stockPortfolio Risk Summary & Free Safe Capital Growth Stock Tips - ulpravda.ru
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Sutro Biopharma, Inc. to Present at 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026 - Quiver Quantitative
Sutro Biopharma lays off dozens of employees in ‘strategic portfolio review’ - MSN
Growth Report: What consensus target says about Sutro Biopharma Inc S09 stockQuarterly Trade Report & Risk Adjusted Buy and Sell Alerts - moha.gov.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of “Hold” by Analysts - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treasury Yields: Can Sutro Biopharma Inc stock beat analyst upgradesGlobal Markets & Growth Focused Entry Reports - moha.gov.vn
Sutro Biopharma, Inc.'s (NASDAQ:STRO) Price Is Right But Growth Is Lacking After Shares Rocket 46% - simplywall.st
Sutro Biopharma (NASDAQ:STRO) Will Have To Spend Its Cash Wisely - Yahoo Finance
Sutro Biopharma, Inc. (NASDAQ:STRO) Held Back By Insufficient Growth Even After Shares Climb 46% - 富途牛牛
Sutro Biopharma Stock Pre-Market (+6.9%): Momentum From Analyst EPS Upgrade - Trefis
Sutro Biopharma FY2025 EPS Forecast Boosted by HC Wainwright - Defense World
FY2025 EPS Estimate for Sutro Biopharma Increased by Analyst - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Down 85.9% in December - MarketBeat
Sutro Biopharma (NASDAQ:STRO) Given New $10.00 Price Target at HC Wainwright - Defense World
HC Wainwright Forecasts Strong Price Appreciation for Sutro Biopharma (NASDAQ:STRO) Stock - MarketBeat
STRO: HC Wainwright Raises Price Target by 400% Today | STRO Sto - GuruFocus
HC Wainwright & Co. Maintains Sutro Biopharma (STRO) Neutral Recommendation - Nasdaq
Is Sutro Biopharma Inc. stock a contrarian buyQuarterly Trade Summary & High Accuracy Investment Entry Signals - Улправда
Is Sutro Biopharma Stock Built to Withstand a Pullback? - Trefis
How rising interest rates impact Sutro Biopharma Inc. stockJuly 2025 Analyst Calls & Expert Verified Stock Movement Alerts - Улправда
Finanzdaten der Sutro Biopharma Inc-Aktie (STRO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):